Human-cl-rhFVIII in Previously Untreated Patients
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Hematology |
| Therapuetic Areas: | Hematology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 3/15/2019 |
| Start Date: | February 2013 |
| End Date: | December 2019 |
Immunogenicity, Efficacy and Safety of Treatment With Human-cl-rhFVIII in Previously Untreated Patients With Severe Hemophilia A
Investigate the inhibitor development rate of Human cl rhFVIII in previously untreated
patients with severe Hemophilia A.
patients with severe Hemophilia A.
Inclusion Criteria:
- Male patients
- Severe Hemophilia A (FVIII:C <1%)
- No previous treatment with with FVIII concentrates or other blood prodcuts containing
FVIII
Exclusion Criteria:
- Diagnosis with a coagulation disorder other than Hemophilia A
- Severe liver or kidney disease
- Concomitant treatment with any systemic immunosuppressive drug
We found this trial at
4
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials